ARCHIVES

ONS Membership Still Climbing, Soars over 15,000

This article is from The Cancer Letter archive.

Vol. 15 No. 25 | June 23, 1989

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

NCI RFP Available.

February 18, 2000

NCAB Hears “Impressive” Progress Reports, Including Treatment for Breast, Liver Cancer, Vaccine Studies

October 18, 1974

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

October 9, 1992

Hydridoma Cell Lines Available

March 5, 1982